Contemporary approaches to saphenous vein graft interventions: A survey of 275 interventional cardiologists

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 5, 2012, Pages 834-842

  Mahmood, Arif ^a   Khair, Tarif ^a   Abdel karim, Abdul Rahman R ^a   Papayannis, Aristotelis ^a   Xu, Hao ^a   Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Embolic protection devices; Percutaneous coronary intervention; Saphenous vein graft interventions

Indexed keywords

ADENOSINE; VASODILATOR AGENT;

ANATOMIC DIFFICULTY; ANATOMICAL CONCEPTS; ANTICOAGULANT THERAPY; ARTICLE; CARDIOLOGIST; CONTROLLED STUDY; DEVICE COMPLEXITY; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; GUIDE WIRE; HEART CATHETERIZATION; HUMAN; MEDICAL DEVICE; PRACTICE GUIDELINE; SAPHENOUS VEIN GRAFT;

ANGIOPLASTY, BALLOON, CORONARY; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; CORONARY THROMBOSIS; CROSS-SECTIONAL STUDIES; EMBOLIC PROTECTION DEVICES; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RADIOLOGY, INTERVENTIONAL; RISK ASSESSMENT; SAFETY MANAGEMENT; SAPHENOUS VEIN; STENTS; UNITED STATES;

EID: 84859439651     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23111     Document Type: Article

References (32)

1. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-2405.
2. Brilakis ES, Saeed B, Banerjee S. Drug-eluting stents in saphenous vein graft interventions: A systematic review. EuroIntervention 2010;5:722-730.
3. Rodes-Cabau J, Bertrand OF, Larose E, Dery J-P, Rinfret S, et al. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions. The moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial. Circulation 2009;120:1978-1986.
4. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: Results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol 2002;14:299-302. (Pubitemid 34651235)
5. Sdringola S, Assali A, Ghani M, Yepes A, Rosales O, Schroth GW, Fujise K, Anderson HV, Smalling RW. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon. Catheter Cardiovasc Interv 2000;51:394-399.
6. Zoghbi GJ, Goyal M, Hage F, Meyers RP, Papapietro SE, Brott BC, Misra VK, Iskandrian AE, Hillegass WB. Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions. J Invasive Cardiol 2009;21:34-39.
7. Fischell TA, Subraya RG, Ashraf K, Perry B, Haller S. "Pharmacologic"distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. J Invasive Cardiol 2007;19:58-62.
8. Banerjee S, Brilakis ES. Embolic protection during saphenous vein graft interventions. J Invasive Cardiol 2009;21:415-417.
9. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, et al. Randomized comparison of distal protection with a filterbased catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553. (Pubitemid 36961168)
10. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, et al. The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: A randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007;50:1442-1449. (Pubitemid 47494591)
11. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290. (Pubitemid 34260417)
12. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: A predictive model derived from a pooled analysis of 3958 patients. Circulation 2008;117:790-797. (Pubitemid 351640680)
13. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv 2006;67:87-112. (Pubitemid 43062614)
14. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-2555.
15. Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 2007;100:1114-1118. (Pubitemid 47404467)
16. Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: A report from the American College of Cardiology National Cardiovascular Data CathPCI registry. J Am Coll Cardiol Interv 2010;3:1068-1073.
17. Baz JA, Pinar E, Albarran A, Mauri J. Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007). Rev Esp Cardiol 2008;61:1298-1314.
18. Cooper L, Banerjee S, Brilakis ES. Crossover from radial to femoral access during a challenging percutaneous coronary intervention can make the difference between success and failure. Cardiovasc Revasc Med 2010;11:266 e5-e8.
19. Ashby DT, Dangas G, Aymong EA, Iakovou I, Kuepper F, Mehran R, Stone GW, Leon MB, Moses JW. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. J Am Coll Cardiol 2003;41:749-752. (Pubitemid 36308380)
20. Grow P, Rab ST. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: Complementing lesion anatomy with embolic protection device. Catheter Cardiovasc Interv 2008;72:636-640.
21. Badhey N, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, et al. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial. Catheter Cardiovasc Interv 2010;76:263-269.
22. Badhey N, Banerjee S, Brilakis ES. Use of embolic protection devices in saphenous vein graft interventions: The ongoing challenge. Catheter Cardiovasc Interv 2011; DOI 10.1002/ccd.22801.
23. Maia F, Costa JR Jr, Abizaid A, Feres F, Costa R, Staico R, Siqueira D, Esteves V, Sousa A, Sousa JE. Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization. Catheter Cardiovasc Interv 2010;76:86-92.
24. Abizaid A, Weiner B, Bailey SR, Londero H. Use of a self-expanding super-elastic all-metal endoprosthesis; To treat degenerated SVG lesions: The SESAME first in man trial. Catheter Cardiovasc Interv 2010;76:781-786.
25. Hong YJ, Pichard AD, Mintz GS, Kim SW, Lee SY, et al. Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Am J Cardiol 2010;105:179-185.
26. Satler LF. Revitalizing embolic protection in saphenous vein grafts. Catheter Cardiovasc Interv 2010;76:270-271.
27. Wood FO, Badhey N, Garcia B, Abdel-karim AR, Maini B, Banerjee S, Brilakis ES. Analysis of saphenous vein graft lesion composition using near-infrared spectroscopy and intravascular ultrasonography with virtual histology. Atherosclerosis 2010;212:528-533.
28. van Gaal WJ, Choudhury RP, Porto I, Channon K, Banning A, Dzavik V, Ramsamujh R, Bui S, Blackman DJ. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 2007;99:603-606.
29. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol 2009;53:919-928.
30. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 2007;50:261-267. (Pubitemid 47039289)
31. Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, et al. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: Insights from the SOS (stenting of saphenous vein grafts) trial. JACC Cardiovasc Interv 2009;2:855-860.
32. Khair T, Garcia BA, Banerjee S, Brilakis ES. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: A survey of 374 interventional cardiologists. Cardiovasc Revasc Med 2010;12:99-104.